YKYu Kang

Yu Kang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yu Kang has a total of 66 co-authors. Here are the top co-authors by number of shared publications:

  • Yuyu Niu

    State Key Laboratory of Primate Biomedical Research, Institute of Primate Translational Medicine, Kunming University of Science and Technology, Kunming, China

    7 shared publications
  • Weizhi Ji

    State Key Laboratory of Primate Biomedical Research, Institute of Primate Translational Medicine, Kunming University of Science and Technology, Kunming, China

    6 shared publications
  • Baohong Tian

    Yunnan Key Laboratory of Primate Biomedical Research , Kunming

    3 shared publications
  • Chenyang Si

    State Key Laboratory of Primate Biomedical Research, Institute of Primate Translational Medicine, Kunming University of Science and Technology , Kunming

    3 shared publications
  • Xinglong Chen

    Yunnan Key Laboratory of Primate Biomedical Research , Kunming

    3 shared publications
  • Zifan Li

    State Key Laboratory of Primate Biomedical Research, Institute of Primate Translational Medicine, Kunming University of Science and Technology , Kunming

    3 shared publications

Latest Publications

  • Open Access

    Efficient production of cynomolgus monkeys via transabdominal uterine puncture embryo transfer

    by Zifan Li, Yu Dong, Xinglong Chen, Baohong Tian, Chenyang Si, Weizhi Ji, Yuyu Niu, Yu Kang

    Embryo transfer is a key application of assisted reproductive technology in non-human primates, underpinning research in reproductive biology, disease modeling, and conservation. The conventional approach—tubal embryo transfer—typically requires a laparoscopy system and abdominal incision to expose the oviducts and reproductive tract for embryo transfer, and is associated with complex procedures, a high cost, and cumulative reproductive tract injury following repeated surgeries. Moreover, implantation and pregnancy rates decline with increasing recipient age and surgical history, highlighting the need for a rapid, simple, and minimally invasive alternative. Here, using cynomolgus monkeys (Macaca fascicularis) as a model, we implemented a transabdominal uterine puncture method. This technique involves the direct introduction of in vitro cultured embryos into the uterine cavity by means of an ultrasound-guided needle. In a cohort of 37 recipients, transabdominal uterine puncture yielded confirmed implantation in 19 animals (51.35%). Importantly, implantation and pregnancy outcomes in older animals and in those with prior reproductive surgeries were substantially higher than rates historically observed with tubal embryo transfer. Gestation assessments and neonatal examinations revealed no discernible abnormalities or increased perinatal complications in offspring produced via transabdominal uterine puncture, compared with controls, supporting the method as an efficient and safe embryo transfer strategy for non-human primates.

  • Open Access

    Production of live monkeys and their genetically matched embryonic stem cells from single embryos

    by Chenyang Si, Ran Zhu, Junmo Wu, Zhenzhen Chen, Zengli Tang, Zuoyao Li, Yu Kang, Lifeng Xiang, Jiawei Zuo, Pengpeng Yang, et al.

    Immune rejection poses a challenge in stem cell therapy, especially with allogeneic embryonic stem cells (ESCs). Non-human primates offer a promising avenue for developing genetically matched ESCs for regenerative medicine. Here, we successfully derive three live monkeys and their genetically matched autologous ESCs (aESCs) using embryo splitting. Additionally, from fibroblasts of one of these monkeys, we generate induced pluripotent stem cells (iPSCs) and nuclear transfer embryonic stem cells (ntESCs), creating a set of genetically matched aESCs, iPSCs, and ntESCs. Single-cell RNA-seq analysis reveals that aESCs potentially exhibit reduced heterogeneity, lower transcriptional noise, and enhanced genomic stability compared to iPSCs and ntESCs. Furthermore, we successfully derive ESCs from human split embryos, highlighting the potential for obtaining human aESCs. Collectively, our study offers an avenue for establishing autologous pluripotent stem cells and provides the theoretical basis as well as research model for further application of aESCs in human regenerative medicine.


  • Open Access

    Highly efficient construction of monkey blastoid capsules from aged somatic cells

    by Junmo Wu, Tianao Shao, Zengli Tang, Gaojing Liu, Zhuoyao Li, Yuxi Shi, Yu Kang, Jiawei Zuo, Bo Zhao, Guangyu Hu, et al.

    Blastoids—blastocyst-like structures created in vitro—emerge as a valuable model for early embryonic development research. Non-human primates stem cell-derived blastoids are an ethically viable alternative to human counterparts, yet the low formation efficiency of monkey blastoid cavities, typically below 30%, has limited their utility. Prior research has predominantly utilized embryonic stem cells. In this work, we demonstrate the efficient generation of blastoids from induced pluripotent stem cells and somatic cell nuclear transfer embryonic stem cells derived from aged monkeys, achieving an 80% formation efficiency. We also introduce a hydrogel-based microfluidics platform for the scalable and reproducible production of size-adjustable, biodegradable blastoid capsules, providing a stable 3D structure and mechanical protection. This advancement in the high-efficiency, scalable production of monkey blastoid capsules from reprogrammed aged somatic cells significantly enhances the study of embryonic development and holds promise for regenerative medicine.


  • Open Access

    Cloning and base editing of GFP transgenic rhesus monkey and off-target analysis

    by Yu Kang, Shaoxing Dai, Yuqiang Zeng, Fang Wang, Pengpeng Yang, Zhaohui Yang, Youwei Pu, Zifan Li, Xinglong Chen, Baohong Tian, et al.

    We report the cloning of a 12-year-old transgenic green fluorescent protein (GFP) monkey by somatic cell nuclear transfer (SCNT) and base editing of the embryos, accompanied with safety evaluation of adenine base editors (ABEs). We first show the ability of ABEmax to silence GFP through A-to-G editing of the GFP sequence in 293T cells. Subsequently, using donor cells from a monkey expressing GFP, we have successfully generated 207 ABEmax-edited (SCNT-ABE) and 87 wild-type (SCNT) embryos for embryo transfer, genotyping, and genome and transcriptome analysis. SCNT-ABE and SCNT embryos are compared for off-target analysis without the interference of genetic variants using a new method named as OA-SCNT. ABEmax does not induce obvious off-target DNA mutations but induces widespread off-target RNA mutations, 35% of which are exonic, in edited monkey embryos. These results provide important references for clinical application of ABE.


  • Open Access

    BRN2 as a key gene drives the early primate telencephalon development

    by Xiaoqing Zhu, Yicheng Guo, Chu Chu, Dahai Liu, Kui Duan, Yu Yin, Chenyang Si, Yu Kang, Junjun Yao, Xuewei Du, et al.

    Evolutionary mutations in primate-specific genes drove primate cortex expansion. However, whether conserved genes with previously unidentified functions also play a key role in primate brain expansion remains unknown. Here, we focus on BRN2 ( POU3F2 ), a gene encoding a neural transcription factor commonly expressed in both primates and mice. Compared to the limited effects on mouse brain development, BRN2 biallelic knockout in cynomolgus monkeys ( Macaca fascicularis ) is lethal before midgestation. Histology analysis and single-cell transcriptome show that BRN2 deficiency decreases RGC expansion, induces precocious differentiation, and alters the trajectory of neurogenesis in the telencephalon. BRN2 , serving as an upstream factor, controls specification and differentiation of ganglionic eminences. In addition, we identified the conserved function of BRN2 in cynomolgus monkeys to human RGCs. BRN2 may function by directly regulating SOX2 and STAT3 and maintaining HOPX . Our findings reveal a previously unknown mechanism that BRN2 , a conserved gene, drives early primate telencephalon development by gaining novel mechanistic functions.


  • Dissecting primate early post-implantation development using long-term in vitro embryo culture

    by Yuyu Niu, Nianqin Sun, Chang Li, Ying Lei, Zhihao Huang, Jun Wu, Chenyang Si, Xi Dai, Chuanyu Liu, Jingkuan Wei, et al.

    In vitro development of monkey embryos: Owing to technical and ethical limitations, the molecular and cellular mechanisms underlying primate gastrulation are far from clear (see the Perspective by Tam). Two independent studies used an in vitro culture system to study cynomolgus monkey embryo postimplantation development up to and beyond gastrulation (day 9 to day 20). Niuet al.observed in vivo morphogenetic events and used single-cell RNA sequencing and single-cell chromatin accessibility to study the distinct cell lineages in developing embryos. Maet al.also observed that key events of in vivo early development were recapitulated in their system, and single-cell RNA-sequencing analysis revealed molecular signatures of postimplantation cell types. These systems will help elucidate the dynamics and regulation of gastrulation in primates, including possible relevance to human development.Science, this issue p.eaaw5754, p.eaax7890; see also p.798


  • Open Access

    CRISPR/Cas9-mediated genome editing in nonhuman primates

    by Yu Kang, Chu Chu, Fang Wang, Yuyu Niu

    Owing to their high similarity to humans, non-human primates (NHPs) provide an exceedingly suitable model for the study of human disease. In this Review, we summarize the history of transgenic NHP models and the progress of CRISPR/Cas9-mediated genome editing in NHPs, from the first proof-of-principle green fluorescent protein-expressing monkeys to sophisticated NHP models of human neurodegenerative disease that accurately phenocopy several complex disease features. We discuss not only the breakthroughs and advantages, but also the potential shortcomings of the application of the CRISPR/Cas9 system to NHPs that have emerged from the expanded understanding of this technology in recent years. Although off-target and mosaic mutations are the main concerns in CRISPR/Cas9-mediated NHP modeling, recent progress in genome editing techniques make it likely that these technical limitations will be overcome soon, bringing excellent prospects to human disease studies.